Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Corporate earnings weigh on stocks ahead of Fed minutes

Tue, 20th Aug 2013 11:41

A number of poorly-received results from blue-chip companies and ongoing concerns about the future of US stimulus weighed heavily on markets on Tuesday morning, dragging the FTSE 100 to levels not seen in over six weeks.London's benchmark index reached an intraday low of around 6,400 early on before trimming losses slightly by midday; still, the last time it closed lower was on July 5th when it finished the day at 6,375.52.Rising US bond yields and speculation about an impending tapering of asset purchases by the Federal Reserve have hit market sentiment over recent weeks. Investors are now choosing to adopt a cautious approach ahead of the minutes of the Federal Open Market Committee (FOMC) meeting due out tomorrow."We're seeing a lot more risk aversion in the markets now, with Asian indices plummeting over night and European stocks following suit this morning. With very little data out over night and again today, investors are clearly preparing themselves ahead of the Fed minutes which will be released on Wednesday," said Market Analyst Craig Erlam from Alpari.While Erlam isn't expecting any surprises from the minutes - given that a potential decision to taper still remains dependent on incoming economic data - he said: "That has never stopped the markets panicking in the past and doesn't look like stopping them now. The markets hate uncertainty."FTSE 100: Wood Group, CRH, miners drop sharplyOil and gas services company Wood Group slumped this morning after scaling back its full-year EBITA growth guidance for its engineering division from 15% to "10-15%", reflecting some project delays and further weakening in Canada. EBITA in the first half was up 18.6% year-on-year.CRH also fell sharply after swinging to a loss for the half-year period. The building materials firm reported a loss before tax of €71m, down from €102m the year before, while sales fell 3.0% to €8.01bn.Mining stocks were also out of favour today as results from BHP Billiton and Glencore Xstrata failed to impress. BHP said lower commodity prices wiped $8.9bn off its underlying earnings which plunged 22.4% in the year to the end of June, while Glencore Xstrata was forced to write down $7.7bn in assets as it reported a 9.0% drop in first-half adjusted EBITDA.Even housebuilder Persimmon fell into the red by midday despite a strong jump early on. The company said that first-half profits jumped 38% and its order book was running 21% ahead of last year as the government's 'Help to Buy' scheme boosted demand.Defensive stocks were in demand today as relatively 'riskier' assets (such as those in the resources sectors) were sold off. Telecom giant BT, utilities peers National Grid and United Utilities and pharmaceutical giant GlaxoSmithKline were all making gains this morning.Meggitt, the engineering group working in the aerospace, defence and energy markets, was slightly higher after Investec upgraded the stock from 'add' to 'buy', saying it still sees further upside even after a strong performance this year.FTSE 100 - RisersCompass Group (CPG) 869.50p +1.40%BT Group (BT.A) 326.30p +1.27%GlaxoSmithKline (GSK) 1,659.00p +0.85%National Grid (NG.) 739.50p +0.82%Meggitt (MGGT) 536.50p +0.75%Aggreko (AGK) 1,680.00p +0.60%British American Tobacco (BATS) 3,410.00p +0.49%Tate & Lyle (TATE) 824.50p +0.49%Vodafone Group (VOD) 190.70p +0.45%British Land Co (BLND) 570.50p +0.44%FTSE 100 - FallersWood Group (John) (WG.) 831.50p -7.92%CRH (CRH) 1,363.00p -4.42%Vedanta Resources (VED) 1,153.00p -3.92%Prudential (PRU) 1,146.00p -3.37%Glencore Xstrata (GLEN) 292.25p -3.21%Standard Chartered (STAN) 1,477.00p -2.89%Lloyds Banking Group (LLOY) 73.08p -2.56%BHP Billiton (BLT) 1,907.50p -2.48%GKN (GKN) 332.10p -2.24%G4S (GFS) 241.50p -1.91%FTSE 250 - RisersFisher (James) & Sons (FSJ) 1,054.00p +5.56%Ladbrokes (LAD) 200.00p +4.44%Crest Nicholson Holdings (CRST) 331.00p +2.41%Hikma Pharmaceuticals (HIK) 1,087.00p +1.40%NMC Health (NMC) 334.50p +1.36%Barr (A.G.) (BAG) 565.00p +1.35%Britvic (BVIC) 562.50p +1.35%Keller Group (KLR) 1,056.00p +1.25%Centamin (DI) (CEY) 37.48p +0.75%Lancashire Holdings Limited (LRE) 750.00p +0.74%FTSE 250 - FallersBrewin Dolphin Holdings (BRW) 259.00p -5.99%Computacenter (CCC) 510.00p -5.38%Hochschild Mining (HOC) 222.10p -4.64%Evraz (EVR) 117.50p -4.55%Ashmore Group (ASHM) 338.40p -4.05%Fenner (FENR) 345.50p -3.81%Inchcape (INCH) 610.50p -3.63%Perform Group (PER) 530.00p -3.55%Utilico Emerging Markets Ltd (DI) (UEM) 167.50p -3.29%Menzies(John) (MNZS) 735.50p -3.16%BC
More News
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more
27 Nov 2023 08:02

GSK receives 'positive' headline results from phase III trial

(Sharecast News) - Drugmaker GSK announced on Monday that it had received positive headline results from a planned interim efficacy analysis from a phase III trial evaluating its elantamab mafodotin asset.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.